Viewing Study NCT00807495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:15 PM
Ignite Modification Date: 2026-02-03 @ 6:07 AM
Study NCT ID: NCT00807495
Status: COMPLETED
Last Update Posted: 2018-03-27
First Post: 2008-12-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
None Mantle Cell Lymphoma View
None Burkitt's Lymphoma View
None T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma View
None Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MLN8237 View
None Alisertib View
None Drug therapy View